# EDGAR Filing Document

**Accession Number:** 0001676163
**File Stem:** 0001213900-26-036949
**Filing Date:** 2026-3
**Character Count:** 40027
**Document Hash:** f7ea3a77612c54e8113014fc5f63c007
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-036949.hdr.sgml**: 20260331

**ACCESSION NUMBER**: 0001213900-26-036949

**CONFORMED SUBMISSION TYPE**: 10-K/A

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260331

**DATE AS OF CHANGE**: 20260331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SS Innovations International, Inc.
- **CENTRAL INDEX KEY:** 0001676163
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 473478854
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-K/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42615
- **FILM NUMBER:** 26817653

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 405, 3RD FLOOR, ILABS INFO TECH CENTRE
- **STREET 2:** UDYOG VIHAR, PHASE III
- **CITY:** GURUGRAM
- **NON US STATE TERRITORY:** HARYANA
- **PROVINCE COUNTRY:** K7
- **ZIP:** 122016
- **BUSINESS PHONE:** (954) 478-1410

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 405, 3RD FLOOR, ILABS INFO TECH CENTRE
- **STREET 2:** UDYOG VIHAR, PHASE III
- **CITY:** GURUGRAM
- **NON US STATE TERRITORY:** HARYANA
- **PROVINCE COUNTRY:** K7
- **ZIP:** 122016

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AVRA Medical Robotics, Inc.
- **DATE OF NAME CHANGE:** 20160601

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-K/A**

**(Amendment No. 1)**

(Mark One)

☒ **ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE**

**SECURITIES AND EXCHANGE ACT OF 1934**

For the fiscal year ended **December 31, 2025**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE** 

**SECURITIES EXCHANGE ACT OF 1934**

For the transition period from _____________ to _____________

Commission file number: **001-42615**

**SS INNOVATIONS INTERNATIONAL, INC.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Florida** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**47-3478854** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(State or Other Jurisdiction of | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(I.R.S. Employer |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporation or Organization) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Identification No.) |

---

**405, 3<sup>rd</sup> Floor, iLabs Info Technology Centre**

**Udyog Vihar, Phase III**

**<u>Gurugram, Haryana 122016, India</u>** 

(Address of Principal Executive Offices)

Registrant's telephone number, including area code: **+91 73375 53469**

**Securities registered under Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.0001 per share | SSII | The Nasdaq Stock Market LLC |

---

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined by Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such a shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (ss.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐

Indicate by check mark whether the registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "**large, accelerated filer**," "**accelerated filer**," "**smaller reporting company**" and "**emerging growth company**" in Rule 12b-2 of the Exchange Act:

Large Accelerated Filer ☐ Accelerated Filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was sold, or the average bid and asked prices of such common equity as of the last business day of the registrant's most recently completed second fiscal quarter: $270,113,872.

The number of shares outstanding of the issuer's common stock, $0.0001 par value, as of March 9, 2026, was 200,231,535 shares.

DOCUMENTS INCORPORATED BY REFERENCE: No documents are incorporated by reference into this Report except those Exhibits so incorporated as set forth in the Exhibit index.

**EXPLANATORY NOTE**

This Amendment No. 1 on Form 10-K/A (this "**Form 10-K/A**") to the Annual Report on Form 10-K of SS Innovations International, Inc. ("**SSi**", "**the Company**", "**we**", "**our**" or "**us**") for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission (the "**SEC**") on March 10, 2026 (the "**Form 10-K**"), is being filed for the purposes of amending Item 15(b) of Part IV of the Form 10-K to include Exhibit 97.1, which was inadvertently omitted in the Form 10-K.

Pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the "**Exchange Act**"), this Form 10-K/A also contains new certifications by the principal executive officer and the principal financial officer as required by Section 302 of the Sarbanes-Oxley Act of 2002. Because no financial statements are included in this Amendment and this Amendment does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4, and 5 of the certifications have been omitted.

Except as described above, this Form 10-K/A does not modify or update the disclosures in, or any exhibits to, the Form 10-K. Furthermore, this Form 10-K/A does not change any previously reported financial results, nor does it reflect any events which occurred subsequent to the filing of the Form 10-K. Accordingly, this Amendment should be read in conjunction with our filings with the SEC subsequent to the filing of the Form 10-K. Information not affected by this Form 10-K/A remains unchanged and reflects the disclosures made at the time the Form 10-K was filed.

**TABLE OF CONTENTS**

---

| | |
|:---|:---|
|  | **Page** |
| **[PART IV](#a_001)** | 1 |
| [Item 15. Exhibits and Financial Statement Schedules](#a_002) | 1 |
| [Signatures](#a_003) | 2 |

---

i

**PART IV**

**Item 15. Exhibits and Financial Statement Schedules.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  ***Exhibits.*** 

---

| | |
|:---|:---|
| **Exhibit<br> Number** | **Description** |
| 3.1(i) | [Amended and Restated Articles of Incorporation<sup>(1)</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000161577417000590/s105290_ex3-1i.htm) |
| 3.1(ii) | [Articles of Amendment to Amended and Restated Articles of Incorporation<sup>(2)</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000121390023031058/ea177122ex3-1_ssinnov.htm) |
| 3.2 | [By-Laws<sup>(1)</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000161577417000590/s105290_ex3-2.htm) |
| 10.1 | [2016 Incentive Stock Plan<sup>(1)+</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000161577417000590/s105290_ex10-1.htm) |
| 10.2 | [Employment Agreement with Dr. Sudhir Srivastava<sup>(3)+</sup>](https://www.sec.gov/Archives/edgar/data/1676163/000121390026010551/ea027412201ex10-2_ssinnovati.htm) |
| 10.3 | [Employment Agreement with Dr. Vishwajyoti P. Srivastava<sup>(3)+</sup>](https://www.sec.gov/Archives/edgar/data/1676163/000121390026010551/ea027412201ex10-3_ssinnovati.htm) |
| 10.4 | [Employment Agreement with Barry F. Cohen<sup>(3)+</sup>](https://www.sec.gov/Archives/edgar/data/1676163/000121390023064089/f10q0623ex10-2_ssinnova.htm) |
| 10.5 | [Services Agreement with Milan Rao <sup>(4)+</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000121390026002572/ea027230501ex10-1_ssinno.htm) |
| 10.6 | [Form of Director Appointment Agreement<sup>(1)+</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000161577417000590/s105290_ex10-6.htm) |
|  | [Form of Indemnification Agreement<sup>(1)+</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000121390026010551/ea027412201ex10-8_ssinnovati.htm) |
| 10.7 | [Form of Indemnification Agreement<sup>(1)+</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000161577417002230/s106100_ex10-8.htm) |
| 10.8 | [Offer Letter and Sanction Letter with HDFC Bank<sup>(3)</sup>](https://www.sec.gov/Archives/edgar/data/1676163/000121390026010551/ea027412201ex10-8_ssinnovati.htm) |
| 14.1 | [Code of Ethical Conduct<sup>(1)</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000161577417000590/s105290_ex10-7.htm) |
| 14.2 | [Insider Trading Policy<sup>(5)</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000121390025031773/ea023761901ex14-2_ssinnova.htm) |
| 21.1 | [List of Subsidiaries<sup>(5)</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000121390025031773/ea023761901ex21-1_ssinnova.htm) |
| 23.1 | [Consent of BDO India Services Private Limited<sup>§</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000121390026025440/ea027792501ex23-1.htm) |
| 31.1 | [Section 302 Certification by Chief Executive Officer<sup>§</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000121390026025440/ea027792501ex31-1.htm) |
| 31.2 | [Section 302 Certification by Chief Financial Officer<sup>§</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000121390026025440/ea027792501ex31-2.htm) |
| 31.3 | [Section 302 Certification by Chief Executive Officer<sup>(6)</sup>](ea028390901ex31-3.htm) |
| 31.4 | [Section 302 Certification by Chief Financial Officer<sup>(6)</sup>](ea028390901ex31-4.htm) |
| 32.1 | [Section 906 Certification by Chief Executive Officer<sup>§</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000121390026025440/ea027792501ex32-1.htm) |
| 32.2 | [Section 906 Certification by Chief Financial Officer<sup>§</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000121390026025440/ea027792501ex32-2.htm) |
| 97.1 | [Clawback Policy<sup>(6)</sup>](ea028390901ex97-1.htm) |
| 99.1 | [Audit Committee Charter<sup>(5)</sup>](https://www.sec.gov/Archives/edgar/data/1676163/000121390025031773/ea023761901ex99-1_ssinnova.htm) |
| 99.2 | [Compensation Committee Charter<sup>(5)</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000121390025031773/ea023761901ex99-2_ssinnova.htm) |
| 99.3 | [Nominating and Corporate Governance Committee Charter<sup>(5)</sup>](http://www.sec.gov/Archives/edgar/data/1676163/000121390025031773/ea023761901ex99-3_ssinnova.htm) |
| 101.INS | Inline XBRL Instance Document.<sup>§</sup> |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document.<sup>§</sup> |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document.<sup>§</sup> |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document.<sup>§</sup> |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document.<sup>§</sup> |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document.<sup>§</sup> |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).<sup>§</sup> |

---

<sup>(1)</sup> Filed as an exhibit to the Company's Registration Statement on Form S-1 (File No. 333-216054) and incorporated herein by reference.

<sup>(2)</sup> Filed as an exhibit to the Company's Current Report on Form 8-K filed on April 19, 2023, and incorporated herein by reference.

<sup>(3)</sup> Filed as an exhibit to the Company's Registration Statement on Form S-1 (File No. 333-293114) and incorporated herein by reference.

<sup>(4)</sup> Filed as an exhibit to the Company's Current Report on Form 8-K, filed on January 8, 2026, and incorporated herein by reference.

<sup>(5)</sup> Filed as an exhibit to the Company's Annual Report on Form 10-K for the year ended December 31, 2024, filed on April 15, 2025, and incorporated herein by reference.

<sup>(6)</sup> Filed herewith.

+ Indicates management contract or compensatory plan or arrangement. <br>§ Previously filed or furnished with the Form 10-K.

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **SS INNOVATIONS INTERNATIONAL, INC.** | **SS INNOVATIONS INTERNATIONAL, INC.** |
| Dated: March 31, 2026 | By: | /s/ Sudhir Prem Srivastava |
|  |  | Sudhir Prem Srivastava, M.D. |
|  |  | Chairman and Chief Executive Officer |
|  |  | (Principal Executive Officer) |

---

---

| | | |
|:---|:---|:---|
| Dated: March 31, 2026 | By: | /s/ Milan Rao |
|  |  | Milan Rao |
|  |  | Global Chief Operating Officer |
|  |  | And Chief Financial Officer |

---

## Exhibit 31.3

**Exhibit 31.3**

**CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER**

**PURSUANT TO** 

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Sudhir Prem Srivastava, M.D., Chairman of the Board and Chief Executive Officer of SS Innovations International, Inc., a Florida corporation (the "**Registrant**"), certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K for the year ended December 31, 2025, of the Registrant; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

---

| | | |
|:---|:---|:---|
| Dated: March 31, 2026 | **SS INNOVATIONS INTERNATIONAL, INC.** | **SS INNOVATIONS INTERNATIONAL, INC.** |
|  | By: | /s/ Sudhir Prem Srivastava |
|  |  | Sudhir Prem Srivastava, M.D.<br> Chairman of the Board and Chief Executive Officer |
|  |  | (Principal Executive Officer) |

---

## Exhibit 31.4

**Exhibit 31.4**

**CERTIFICATION OF THE CHIEF FINANCIAL OFFICER**

**PURSUANT TO** 

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Milan Rao, Global Chief Operating Officer and Chief Financial Officer of SS Innovations International, Inc., a Florida corporation (the "**Registrant**"), certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K for the year ended December 31, 2025, of the Registrant; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

---

| | | |
|:---|:---|:---|
| Dated: March 31, 2026 | **SS INNOVATIONS INTERNATIONAL, INC.** | **SS INNOVATIONS INTERNATIONAL, INC.** |
|  | By: | /s/ Milan Rao |
|  |  | Milan Rao<br> Global Chief Operating Officer and<br> Chief Financial Officer |
|  |  | (Principal Financial and Accounting Officer) |

---

## Exhibit 97.1

**Exhibit 97.1**

**SS INNOVATIONS INTERNATIONAL, INC.**

**POLICY FOR THE**

**RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION**

The Board of Directors (the "**Board**") of SS Innovations International, Inc. (the "**Company**"), acting in the best interest of the Company and its shareholders, has adopted this Policy for the Recovery of Erroneously Awarded Compensation (the "**Policy**"), which provides for the recovery of certain Incentive-Based Compensation (as defined below) in the event of an Accounting Restatement (as defined below). This Policy is designed to comply with, and shall be interpreted to be consistent with, Section 10D of the Securities Exchange Act of 1934, as amended ("**Section 10D**"), Rule 10D-1 promulgated under the Securities Exchange Act of 1934, as amended ("**Rule 10D-1**") and Nasdaq Listing Rule 5608 ("**Rule 5608**").

All capitalized terms used and not otherwise defined herein shall have the meanings set forth in Section 2, below.

1. <u>Administration</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1** Except as specifically set forth herein, this Policy will be administered by the Compensation Committee,
composed entirely of independent directors (the "**Compensation Committee** "). The Compensation Committee is authorized
to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this
Policy and for the Company's compliance with the Rule 5608, Section 10D, Rule 10D-1 and any other applicable law, regulation, rule
or interpretation of the Securities Exchange Commission ()"**SEC**") or Nasdaq promulgated or issued in connection therewith.
Any determinations made by the Compensation Committee will be final and binding on all affected individuals and need not be uniform with
respect to each individual covered by the Policy. The Compensation Committee is authorized and directed to consult with the full Board
or such other committees of the Board as may be necessary or appropriate as to matters within the scope of such other committee's
responsibility and authority. Subject to applicable law, the Compensation Committee may authorize and empower any officer or employee
of the Company to take any and all actions necessary or appropriate to carry out the purpose and intent of this Policy, other than with
respect to any recovery under this Policy involving such officer or employee.

2. <u>Definitions</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.1** "**Accounting Restatement**" means an accounting restatement of the Company's financial
statements due to the Company's material noncompliance with any financial reporting requirement under the securities laws, including
any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued
financial statements (a "**Big R**" restatement), or that would result in a material misstatement if the error were corrected
in the current period or left uncorrected in the current period (a "**little r**" restatement).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.2** "**Applicable Period**" means the three completed fiscal years immediately preceding the
date on which the Company is required to prepare an Accounting Restatement, as well as any transition period resulting from a change in
the Company's fiscal year within or immediately following those three completed fiscal years, except that a transition period comprising
a period of at least nine months shall count as a completed fiscal year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.3**  ***"* Clawback Eligible Incentive Compensation**" means all Incentive-Based Compensation
Received by an Executive Officer (i) on or after the Effective Date, regardless of if the Incentive-Based Compensation results from a
compensation contract or arrangement existing prior to the Effective Date, (ii) after beginning service as an Executive Officer, (iii)
who served as an Executive Officer at any time during the applicable performance period relating to any Incentive-Based Compensation,
whether or not such Executive Officer is serving at the time the Erroneously Awarded Compensation is required to be repaid to the Company,
(iv) while the Company has a class of securities listed on a national securities exchange or a national securities association, and (v)
during the Applicable Period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.4** "**Erroneously Awarded Compensation**" means, with respect to each Executive Officer in
connection with an Accounting Restatement, the amount of Clawback Eligible Incentive Compensation that exceeds the amount of Incentive-Based
Compensation that otherwise would have been Received had it been determined based on the restated amounts, computed without regard to
any taxes paid.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.5** "**Executive Officer**" means the Company's current and former executive officers,
as determined by the Compensation Committee in accordance with the Rule 5608, Section 10D and Rule 10D-1, and such other senior executives
who may from time to time be deemed subject to the Policy by the Compensation Committee including but not limited to each individual who
is currently or was previously designated as the Company's president, principal financial officer, principal accounting officer,
controller, any vice-president of the Company in charge of a principal business unit, division, or function, such as sales, administration,
or finance, any other officer or person who performs a significant policy-making function for the Company, the Company's parent(s)
or subsidiaries.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.6** "**Financial Reporting Measure**" is any measure that is determined and presented in accordance
with the accounting principles used in preparing the Company's financial statements, and any measure that is derived wholly or in
part from such measure. Financial Reporting Measures include but are not limited to the following (and any measures derived from the following):
Company stock price; total shareholder return ()"**TSR** "); revenues, net income, operating income, profitability of one
or more reportable segments; financial ratios (e.g., accounts receivable turnover and inventory turnover rates); earnings before interest,
taxes, depreciation and amortization ()"**EBITDA** "); funds from operations and adjusted funds from operations; liquidity
measures (e.g., working capital, operating cash flow); return measures (e.g., return on invested capital, return on assets); earnings
measures (e.g., earnings per share); revenue per user, or average revenue per user, where revenue is subject to an Accounting Restatement;
any of such financial reporting measure relative to a peer group, where the Company's financial reporting measure is subject to
an Accounting Restatement; and tax basis income. For the avoidance of doubt, any Financial Reporting Measures need not be presented within
the Company's financial statements or included in a filing with the SEC.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.7** "**Incentive-Based Compensation**" means any compensation that is granted, earned or voted
based wholly or in part upon the attainment of a Financial Reporting Measure including, but not limited to, compensation in the form of
cash, equity, and phantom equity incentive awards granted under an annual or long term incentive plan, or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.8** "**Nasdaq**" means The Nasdaq Stock Market.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.9** "**Received**" means, with respect to any Incentive-Based Compensation, actual or deemed
receipt of any compensation during the Company's fiscal period during which the Financial Reporting Measure specified in an Incentive-Based
Compensation award is determined and presented, even if the payment or grant of such Incentive-Based Compensation occurs after the end
of that period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.10** **"Restatement Date**" means the earlier to occur of (i) the date the Board, a committee
of the Board, or the officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably
should have concluded, that the Company is required to prepare an Accounting Restatement, or (ii) the date a court, regulator or other
legally authorized body directs the Company to prepare an Accounting Restatement, in each case regardless of if or when the restated financial
statements are filed.

3. <u>Required Recoupment of Erroneously Awarded Compensation in the Event of an Accounting Restatement</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.1** In the event the Company is required to prepare an Accounting Restatement, the Company shall promptly
recoup the amount of any Erroneously Awarded Compensation Received by any Executive Officer in accordance with the Rule 5608 and Rule
10D-1 as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Following an Accounting Restatement, the Compensation Committee will assess the amount of any Erroneously
Awarded Compensation Received by each Executive Officer and shall promptly provide written notice to each Executive Officer detailing
the amount of any Erroneously Awarded Compensation and a demand for repayment or return of such compensation, as applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. In the case of Incentive-Based Compensation based on (or derived from) the Company's stock price
or TSR, where the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information
in the applicable Accounting Restatement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Compensation Committee shall determine the amount to be repaid or returned based on a reasonable estimate
of the effect of the Accounting Restatement on the Company's stock price or TSR upon which the Incentive-Based Compensation was
Received; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The Company shall maintain documentation of the determination of such reasonable estimate and provide
such documentation to the Nasdaq.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. The Compensation Committee shall have discretion to determine the appropriate means of recovering Erroneously
Awarded Compensation based on the particular facts and circumstances. Acceptable methods of recovery include, but are not limited to,
(i) seeking reimbursement, in whole or in part, of any cash or equity-based award, (ii) cancelling prior cash or equity-based awards,
(iii) cancelling or offsetting against any compensation otherwise owed by the Company to the Executive Officer, (iv) forfeiture of deferred
compensation, provided that such forfeiture complies with section 409A of the Internal Revenue Code of 1986, as amended and the regulations
promulgated thereunder and (v) any other means permitted by applicable law or contract. The Compensation Committee, in accordance with
applicable law, may recover under this Policy from any amount otherwise payable to the Executive Officer, including amounts that would
otherwise be payable to such Executive Officer. This includes moneys owed to the Executive Officer under any Company plan or program,
including base salary, bonuses, commissions or previously deferred compensation. The Compensation Committee may in its discretion, establish
a deferred payment plan for the Executive Officer if it determines that repayment of the Erroneously Awarded Compensation would result
in economic hardship for the Executive Officer. Furthermore, the Company and its directors and officers shall factor in the time adjusted
value of potentially recoverable compensation, when determining the appropriate means of recovery. Notwithstanding the foregoing, except
as set forth in Section 3.2 below, the Company is prohibited from accepting an amount less than the amount of Erroneously Awarded Compensation
in satisfaction of an Executive Officer's obligations hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Where the Executive Officer has already reimbursed the Company for any Erroneously Awarded Compensation
Received under a separate recovery obligation established by the Company or applicable law, any such reimbursed amount may be credited
against the amount of Erroneously Awarded Compensation subject to recovery under this Policy. Recovery under this Policy does not preclude
recovery under Sarbanes-Oxley Act Section 304, to the extent any applicable amounts have not been reimbursed to the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. In the event an Executive Officer does not repay all Erroneously Awarded Compensation to the Company when
due, the Company shall take all actions reasonable and appropriate to recover the remaining Erroneously Awarded Compensation from the
applicable Executive Officer. The applicable Executive Officer shall be liable to the Company for any and all expenses reasonably incurred
by the Company (including legal fees) in recovering such Erroneously Awarded Compensation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.2** The Company must recover Erroneously Awarded Compensation in compliance with this Policy unless the Compensation
Committee determines that recovery would be impracticable for the following reasons, and subject to the following procedural and disclosure
requirements:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. The direct costs payable to a third party to assist in enforcing the Policy would exceed the Erroneously
Awarded Compensation amount. Before concluding that it would be impracticable to recover any such amount of Erroneously Awarded Compensation
based on expense of recovery, the Compensation Committee must make a reasonable attempt to recover such Erroneously Awarded Compensation,
document its efforts and provide such documentation to the Nasdaq. Additionally, the Company must disclose the amount of Erroneously Awarded
Compensation foregone and a brief description why the Company did not pursue recovery on the Company's annual report on Form 10-K
and proxy or information statements requiring an Item 402 disclosure; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Recovery would violate home country law where that law was adopted prior to November 28, 2022, provided
that, before determining that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on violation of
home country law, the Company has obtained an opinion of home country counsel, acceptable to the Nasdaq, that recovery would result in
such a violation and a copy of the opinion is provided to Nasdaq; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly
available to employees of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and regulations thereunder.

4. <u>Prohibition of Indemnification</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.1** The Company shall not insure or indemnify any Executive Officer against (i) the loss of any Erroneously
Awarded Compensation that is repaid, returned or recovered pursuant to the terms of this Policy, or (ii) any claims relating to the Company's
enforcement of its rights under this Policy. Further, the Company shall not enter into any agreement that exempts any Incentive-Based
Compensation granted, paid or awarded to an Executive Officer from the application of this Policy or that waives the Company's right
to recover any Erroneously Awarded Compensation. This Policy shall supersede any such agreement, whether entered into before, on or after
the Effective Date of this Policy.

5. <u>Compensation Committee Indemnification</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.1** Members of the Compensation Committee, and any other members of the Board involved in the administration
of this Policy, shall not be personally liable for any action, determination or interpretation made in relation to this Policy and shall
be fully indemnified by the Company to the fullest extent permitted under applicable law and Company policy with respect to any such action,
determination or interpretation. The foregoing sentence shall not limit any other rights to indemnification of the members of the Compensation
Committee under applicable law or Company policy. Notwithstanding Section 7.1, no amendment to this Policy may retroactively limit or
reduce the rights of the members of the Compensation Committee to the protections provided under this Section 5.1.

6. <u>Effective Date; Retroactive Application</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.1** This Policy shall be effective as of the date approved by the Board (the "**Effective Date** "). The terms
of this Policy shall apply to any Incentive-Based Compensation that is Received by Executive Officers on or after the Effective Date,
even if such Incentive-Based Compensation was approved, awarded, granted or paid to such Executive Officers prior to the Effective Date.
Notwithstanding Section 3 hereof, and subject to applicable law, the Compensation Committee may recover under this Policy from any amount
of compensation approved, awarded, granted, payable or paid to the Executive Officer prior to, on or after the Effective Date.

7. <u>Amendment; Termination</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.1** The Board has full discretion to amend, modify, supplement, rescind or replace all or any portion of this
Policy at any time, except that no amendment or termination of this Policy shall be effective if such amendment or termination would cause
the Company to violate any federal securities laws, SEC rule or Nasdaq rule.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.2** This Policy is intended to comply with the definitions and obligations set forth under the Rule 5608,
Section 10D, Rule 10D-1 and any other applicable law, regulation, rule or interpretation of the SEC or Nasdaq promulgated or issued in
connection therewith as of the Effective Date. This Policy shall be deemed to automatically update to conform to any amendment to the
definitions and obligations set forth under the Rule 5608, Section 10D, Rule 10D-1 and any other applicable law, regulation, rule or interpretation
of the SEC or Nasdaq promulgated or issued in connection therewith that are effective as of a date that is after the Effective Date.

8. <u>Other Recovery Rights</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8.1** This Policy shall be binding and enforceable against all Executive Officers and, as required by applicable
law or guidance from the SEC or Nasdaq, their beneficiaries, heirs, executors, administrators or other legal representatives. This Policy
shall be applied to the fullest extent allowed under applicable law. Any employment agreement, equity award agreement, compensatory plan
or other agreement or arrangement with an Executive Officer shall be construed to incorporate, as a condition to the grant of any benefit
thereunder, an agreement by the Executive Officer to abide by the terms of this Policy. This Policy shall supersede any prior policy of
the Company to the extent that any prior policy of the Company does not comply with the standards required under the Rule 5608 and Rule
10D-1. Any right of recovery under this Policy is in addition to, and not in lieu of, any other remedies or rights of recovery that may
be available to the Company under applicable law, regulation, rule or pursuant to the terms of any Company policy, employment agreement,
equity award agreement, compensatory plan, or other arrangement.

9. <u>Disclosure Requirements</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.1** The Company shall file all disclosures with respect to this Policy as required by applicable SEC filing
rules and requirements. A copy of this Policy and any amendments thereto shall be posted on the Company's website and filed as an
exhibit to the Company's annual report on Form 10-K. Pursuant to Regulation S-K, the Company shall disclose any instance in which
the Company is required to prepare an Accounting Restatement.

**ATTESTATION AND ACKNOWLEDGEMENT OF POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION**

I, the undersigned, affirm and acknowledge that I am fully bound by, and subject to, all of the terms and conditions of SS Innovations International, Inc.'s Policy for the Recovery of Erroneously Awarded Compensation, as may be amended, restated, supplemented or otherwise modified from time to time, (the "**Policy**"). In the event of any inconsistency between the Policy and the terms of any employment agreement to which I am a party, or the terms of any compensation plan, program or agreement under which any compensation has been granted, awarded, earned or paid, the terms of the Policy shall govern. In the event the Compensation Committee determines that any amounts granted, awarded, earned or paid to me must be forfeited or reimbursed to the Company, I will promptly take any action necessary to effectuate such forfeiture and/or reimbursement. Any capitalized terms used in this Acknowledgment without definition shall have the meaning set forth in the Policy.

---

| | |
|:---|:---|
| By: | Date: |
| Name: |  |
| Title: |  |

---